It was the latest twist in a nearly decade-long push for easier access to emergency contraception, and the development shocked women’s groups and maker Teva Pharmaceuticals, which had been gearing up for over-the-counter sales to begin by month’s end.
“We are outraged that this administration has let politics trump science,” said Kirsten Moore of the Reproductive Health Technologies Project, an advocacy group. “There is no rationale for this move.”
“This decision is stunning. I had come to believe that the FDA would be allowed to make decisions based on science and the public’s health,” said Susan Wood of George Washington University, who served as the FDA’s top women’s health official until resigning in 2005 to protest delays in deciding Plan B’s fate. She said, “Sadly, once again, FDA has been over-ruled and not allowed to do its job.”
But the decision pleased conservative critics of the proposal.
“Take the politics out of it and it’s a decision that reflects the concerns that many parents in America have,” said Wendy Wright, an evangelical Christian activist who has helped lead the opposition to Plan B.